JP7170002B2 - 皮膚科治療におけるガラクトオリゴ糖およびキシリトールの抗菌活性 - Google Patents

皮膚科治療におけるガラクトオリゴ糖およびキシリトールの抗菌活性 Download PDF

Info

Publication number
JP7170002B2
JP7170002B2 JP2019571649A JP2019571649A JP7170002B2 JP 7170002 B2 JP7170002 B2 JP 7170002B2 JP 2019571649 A JP2019571649 A JP 2019571649A JP 2019571649 A JP2019571649 A JP 2019571649A JP 7170002 B2 JP7170002 B2 JP 7170002B2
Authority
JP
Japan
Prior art keywords
formulation
galacto
oligosaccharides
xylitol
topical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019571649A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020525460A5 (https=
JPWO2019002421A5 (https=
JP2020525460A (ja
Inventor
ザナルディ、アンドレア
チェラキ、アレッサンドラ
モンタルド、イヴァン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rottapharm SpA
Original Assignee
Rottapharm SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rottapharm SpA filed Critical Rottapharm SpA
Publication of JP2020525460A publication Critical patent/JP2020525460A/ja
Publication of JP2020525460A5 publication Critical patent/JP2020525460A5/ja
Publication of JPWO2019002421A5 publication Critical patent/JPWO2019002421A5/ja
Application granted granted Critical
Publication of JP7170002B2 publication Critical patent/JP7170002B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/062—Oil-in-water emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/604—Alkylpolyglycosides; Derivatives thereof, e.g. esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/592—Mixtures of compounds complementing their respective functions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
JP2019571649A 2017-06-27 2018-06-27 皮膚科治療におけるガラクトオリゴ糖およびキシリトールの抗菌活性 Active JP7170002B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762525489P 2017-06-27 2017-06-27
US62/525,489 2017-06-27
PCT/EP2018/067337 WO2019002421A1 (en) 2017-06-27 2018-06-27 ANTIBACTERIAL ACTIVITY OF GALACTO-OLIGOSACCHARIDE AND XYLITOL IN DERMATOLOGICAL TREATMENTS

Publications (4)

Publication Number Publication Date
JP2020525460A JP2020525460A (ja) 2020-08-27
JP2020525460A5 JP2020525460A5 (https=) 2022-02-15
JPWO2019002421A5 JPWO2019002421A5 (https=) 2022-02-15
JP7170002B2 true JP7170002B2 (ja) 2022-11-11

Family

ID=62816525

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019571649A Active JP7170002B2 (ja) 2017-06-27 2018-06-27 皮膚科治療におけるガラクトオリゴ糖およびキシリトールの抗菌活性

Country Status (12)

Country Link
US (1) US11234997B2 (https=)
EP (2) EP4241855A3 (https=)
JP (1) JP7170002B2 (https=)
KR (1) KR102675209B1 (https=)
AU (1) AU2018293307B2 (https=)
BR (1) BR112019027089B1 (https=)
ES (1) ES2948510T3 (https=)
MY (1) MY203497A (https=)
NZ (1) NZ759173A (https=)
PH (1) PH12019502874A1 (https=)
SA (1) SA519410993B1 (https=)
WO (1) WO2019002421A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201900031D0 (en) * 2019-01-02 2019-02-13 Rottapharm Spa Antibacterial oral compositions
GB201911071D0 (en) * 2019-08-02 2019-09-18 Meda Pharma S P A Antibacterial activity of selected prebiotic oligosaccharides and xylitol in dermatological treatment
JP2023516922A (ja) * 2020-02-25 2023-04-21 ユニリーバー・アイピー・ホールディングス・ベスローテン・ヴェンノーツハップ プレバイオティックな有益性のための糖類とグリセロールの組み合わせの使用
DE102020133860A1 (de) 2020-12-16 2022-06-23 MNT Systeme GmbH VERWENDUNG VON β-GALAKTOOLIGOSACCHRIDEN FÜR DIE HERSTELLUNG EINER KOSMETISCHEN UND/ODER PHARMAKOLOGISCH WIRKSAMEN ZUSAMMENSETZUNG
JP2022102000A (ja) * 2020-12-25 2022-07-07 物産フードサイエンス株式会社 吸血昆虫の誘引抑制剤および吸血昆虫誘引菌の菌数抑制剤
JPWO2022230925A1 (https=) * 2021-04-28 2022-11-03

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000302673A (ja) 1999-04-22 2000-10-31 Shiseido Co Ltd アトピー性皮膚炎用皮膚外用剤
JP2000302674A (ja) 1999-04-22 2000-10-31 Shiseido Co Ltd 選択的抗菌組成物
JP2002302404A (ja) 2001-04-02 2002-10-18 Shiseido Co Ltd 抗菌防黴助剤
JP2008156308A (ja) 2006-12-26 2008-07-10 Lion Corp 口腔用組成物
JP2015507011A (ja) 2012-02-14 2015-03-05 ザ プロクター アンド ギャンブルカンパニー 皮膚共生プレバイオティック剤及びそれを含有する組成物の局所使用
JP2016196435A (ja) 2015-04-06 2016-11-24 コーベビオケミア株式会社 スキンケア用組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2678166B1 (fr) * 1991-06-27 1993-10-22 Bioeurope Compositions cosmetiques contenant des glucooligosaccharides.
JP5207664B2 (ja) 2007-06-04 2013-06-12 株式会社シャネル化粧品技術開発研究所 化粧品
CN103462881B (zh) * 2013-10-10 2016-06-22 深圳市容大生物技术有限公司 一种可促进皮肤微生态平衡的组合物及其制备方法
CN104970176A (zh) * 2015-07-02 2015-10-14 广州普正生物科技有限公司 复合真菌多糖凝胶糖果
CN105796377A (zh) 2016-03-18 2016-07-27 西安膳方医药科技有限公司 一种通过微生态调整改善生物体表健康的方法
AU2017240656A1 (en) * 2016-03-31 2018-11-15 Gojo Industries, Inc. Topical composition for reducing pathogen binding
CN106071033A (zh) 2016-05-12 2016-11-09 南京泽朗生物科技有限公司 一种含益生元的冰激凌及其制备方法
CN106616602A (zh) 2016-12-09 2017-05-10 宁夏沃福百瑞枸杞产业股份有限公司 一种黑枸杞益生菌片的制备方法

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000302673A (ja) 1999-04-22 2000-10-31 Shiseido Co Ltd アトピー性皮膚炎用皮膚外用剤
JP2000302674A (ja) 1999-04-22 2000-10-31 Shiseido Co Ltd 選択的抗菌組成物
JP2002302404A (ja) 2001-04-02 2002-10-18 Shiseido Co Ltd 抗菌防黴助剤
JP2008156308A (ja) 2006-12-26 2008-07-10 Lion Corp 口腔用組成物
JP2015507011A (ja) 2012-02-14 2015-03-05 ザ プロクター アンド ギャンブルカンパニー 皮膚共生プレバイオティック剤及びそれを含有する組成物の局所使用
JP2016196435A (ja) 2015-04-06 2016-11-24 コーベビオケミア株式会社 スキンケア用組成物

Also Published As

Publication number Publication date
PH12019502874A1 (en) 2020-10-05
ES2948510T3 (es) 2023-09-13
NZ759173A (en) 2022-11-25
WO2019002421A1 (en) 2019-01-03
RU2020102673A3 (https=) 2021-09-10
MY203497A (en) 2024-06-30
KR20200024786A (ko) 2020-03-09
KR102675209B1 (ko) 2024-06-17
EP4241855A2 (en) 2023-09-13
AU2018293307A1 (en) 2019-12-05
US20200171070A1 (en) 2020-06-04
EP4241855A3 (en) 2023-10-25
EP3644945C0 (en) 2023-06-07
SA519410993B1 (ar) 2023-10-16
JP2020525460A (ja) 2020-08-27
BR112019027089B1 (pt) 2023-04-25
AU2018293307B2 (en) 2023-09-21
US11234997B2 (en) 2022-02-01
EP3644945A1 (en) 2020-05-06
EP3644945B1 (en) 2023-06-07
BR112019027089A2 (pt) 2020-07-07
RU2020102673A (ru) 2021-07-27

Similar Documents

Publication Publication Date Title
JP7170002B2 (ja) 皮膚科治療におけるガラクトオリゴ糖およびキシリトールの抗菌活性
JP6429131B2 (ja) 膣症を予防および治療するために塩および糖を有効成分として含む皮膚外用組成物およびその使用
WO2021023695A1 (en) Combinations of oligosaccharides and xylitol for dermatological treatment
JP2019524636A (ja) 膣症の予防及び治療のための乳酸菌を含む組成物、並びにその使用
JPH11504049A (ja) ツツジ科の植物種より由来する物質および乳酸バクテリア成長因子を含む泌尿生殖器および腸の疾患用の組成物
US10413575B2 (en) Pharmaceutical composition for preventing or treating inflammatory diseases, containing Lactococcus chungangensis as active ingredient
KR102587444B1 (ko) 미생물총의 건강한 균형을 유지하기 위한 상승 조성물
WO2021250155A1 (en) Novel use
KR20230165382A (ko) 락토바실러스 우세를 유지하기 위한 조성물
KR101838404B1 (ko) 올리고키토산을 유효성분으로 함유하는 여드름 예방 또는 치료용 조성물
JP7767471B2 (ja) 少なくとも１つの酸化防止剤とビフィドバクテリウム属（Ｂｉｆｉｄｏｂａｃｔｅｒｉｕｍ）種溶解物とを含む組成物の適用を含む美容的処置法
US11413305B2 (en) Use of agar-derived oligosaccharides for inhibiting growth of Staphylococcus
JP2017075098A (ja) 動物用の口腔用組成物並びにそれを使用した動物用の歯周病予防剤及び動物用の口臭予防剤
RU2780618C2 (ru) Антибактериальная активность галактоолигосахарида и ксилита в дерматологических лечениях
JP7767470B2 (ja) 特定の抗酸化剤、特定の脂肪酸エステル、ビフィドバクテリウム属（Ｂｉｆｉｄｏｂａｃｔｅｒｉｕｍ）種溶解物及び酵母エキスを含む組成物
HK40021213B (en) Antibacterial activity of galactooligosaccharide and xylitol in dermatological treatments
HK40021213A (en) Antibacterial activity of galactooligosaccharide and xylitol in dermatological treatments
JP2023084325A (ja) デーデルライン桿菌の増殖促進剤および微生物選択的増殖促進剤
WO2023006620A1 (en) Composition comprising an antioxidant, a monosaccharide, a bifidobacterium species lysate and a yeast extract
US8673865B2 (en) Agent for enhancing antiseptic power
JP2024127663A (ja) 皮膚の短鎖脂肪酸生成促進剤
FR3132023A1 (fr) Ingredient protecteur de la peau et/ou des muqueuses contre les facteurs de virulence

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210625

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220203

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20220318

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220401

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220628

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220901

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20221007

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20221031

R150 Certificate of patent or registration of utility model

Ref document number: 7170002

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150